Tessa Therapeutics is a biotechnology company focused on developing innovative T cell therapies for the treatment of cancer, particularly solid tumors and lymphoma. The company specializes in creating virus-specific T cells and CAR T cells, leveraging the body's natural immune response to target and eliminate cancer cells. By advancing both autologous and allogeneic cell therapy approaches, Tessa Therapeutics aims to transform cancer treatment, providing healthcare providers with new tools to improve patient outcomes and enhance the quality of life for those affected by cancer.
Euchloe Bio specializes in the discovery, development, engineering and commercialization of novel, fully-human antibodies for the treatment of cancer, using its proprietary antibody engineering technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.